Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

[Endothelium-derived hyperpolarizing factor (EDHF): potential involvement in the physiology and pathology of blood vessels].

Kozłowska H, Baranowska M, Gromotowicz A, Malinowska B.

Postepy Hig Med Dosw (Online). 2007 Oct 12;61:555-64. Review. Polish.

2.

Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease.

Coleman HA, Tare M, Parkington HC.

Clin Exp Pharmacol Physiol. 2004 Sep;31(9):641-9. Review.

PMID:
15479173
3.

Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans.

Bellien J, Thuillez C, Joannides R.

Fundam Clin Pharmacol. 2008 Aug;22(4):363-77. doi: 10.1111/j.1472-8206.2008.00610.x. Review.

PMID:
18705747
4.

Hydrogen peroxide as an endothelium-derived hyperpolarizing factor.

Shimokawa H, Matoba T.

Pharmacol Res. 2004 Jun;49(6):543-9. Review.

PMID:
15026032
5.

Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans.

Matoba T, Shimokawa H.

J Pharmacol Sci. 2003 May;92(1):1-6. Review.

6.

Endothelium-dependent hyperpolarization of vascular smooth muscle cells.

Félétou M, Vanhoutte PM.

Acta Pharmacol Sin. 2000 Jan;21(1):1-18. Review.

7.

Endothelium-derived hyperpolarizing factor.

Félétou M, Vanhoutte PM.

Clin Exp Pharmacol Physiol. 1996 Dec;23(12):1082-90. Review.

PMID:
8977164
8.

Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.

Grgic I, Kaistha BP, Hoyer J, Köhler R.

Br J Pharmacol. 2009 Jun;157(4):509-26. doi: 10.1111/j.1476-5381.2009.00132.x. Epub 2009 Mar 19. Review.

9.

Endothelium-derived hyperpolarising factors and associated pathways: a synopsis.

Edwards G, Félétou M, Weston AH.

Pflugers Arch. 2010 May;459(6):863-79. doi: 10.1007/s00424-010-0817-1. Epub 2010 Apr 11. Review.

PMID:
20383718
10.

Endothelium-derived hyperpolarizing factor: where are we now?

Félétou M, Vanhoutte PM.

Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1215-25. Epub 2006 Mar 16. Review.

12.

Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Félétou M.

Br J Pharmacol. 2009 Feb;156(4):545-62. doi: 10.1111/j.1476-5381.2009.00052.x. Epub 2009 Jan 29. Review.

13.
14.

Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations.

Nagao T, Vanhoutte PM.

Am J Respir Cell Mol Biol. 1993 Jan;8(1):1-6. Review.

PMID:
8380248
15.

The third pathway: endothelium-dependent hyperpolarization.

Félétou M, Vanhoutte PM.

J Physiol Pharmacol. 1999 Dec;50(4):525-34. Review.

PMID:
10639003
16.

[Role of nitric oxide and other endothelium-derived factors].

Stankevicius E, Kevelaitis E, Vainorius E, Simonsen U.

Medicina (Kaunas). 2003;39(4):333-41. Review. Lithuanian.

17.

[Recent advances in the study of endothelium-dependent hyperpolarizing factor (EDHF)].

Suzuki H.

Nihon Yakurigaku Zasshi. 2003 Feb;121(2):85-90. Review. Japanese.

PMID:
12616853
18.

Endothelium-derived hyperpolarizing factor: is there a novel chemical mediator?

Triggle CR, Ding H.

Clin Exp Pharmacol Physiol. 2002 Mar;29(3):153-60. Review.

PMID:
11906476
19.

[Endothelium-derived hyperpolarizing factor and vasodilatation].

Suzuki H, Yamamoto Y, Fukuta H.

Nihon Yakurigaku Zasshi. 1998 Sep;112(3):195-202. Review. Japanese.

PMID:
9793074
20.

Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses.

de Wit C, Griffith TM.

Pflugers Arch. 2010 May;459(6):897-914. doi: 10.1007/s00424-010-0830-4. Epub 2010 Apr 9. Review.

PMID:
20379740

Supplemental Content

Support Center